Animal models of herpes simplex virus immunity and pathogenesis

Journal of NeuroVirology

Volumn 21, Issue 1, 2015, Pages 8-23

  Kollias, Christina M ^a   Huneke, Richard B ^a   Wigdahl, Brian ^a   Jennings, Stephen R ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Animal models; Herpes simplex virus; Immunity; Pathogenesis

Indexed keywords

MESSENGER RNA; METHYLPREDNISOLONE; TOLL LIKE RECEPTOR 9 ANTAGONIST; TOLL LIKE RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; DISEASE PREDISPOSITION; DISTRESS SYNDROME; EYE INFECTION; GANGLION; GENE EXPRESSION; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; INNATE IMMUNITY; INOCULATION; LIP INFECTION; MOLECULAR BIOLOGY; MOUSE STRAIN; MOUTH INFECTION; NONHUMAN; PAIN; PATHOGENESIS; PRIMARY INFECTION; PRIORITY JOURNAL; RABBIT; REVIEW; SKIN INFECTION; VIRUS IMMUNITY; VIRUS LATENCY; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; DISEASE MODEL; GUINEA PIG; HUMAN; MOUSE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SENSORY GANGLION; SPECIES DIFFERENCE; VIROLOGY; VIRUS ACTIVATION; VIRUS ENCEPHALITIS;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; GANGLIA, SENSORY; GUINEA PIGS; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNITY, INNATE; MICE; RABBITS; SPECIES SPECIFICITY; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84925532827     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0302-2     Document Type: Review

References (157)

1. Ahmed M, Lock M, Miller CG, Fraser NW (2002) Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J Virol 76:717–729. doi:10.1128/JVI. 76.2.717-729.2002
2. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153–162. doi:10.1016/j.immuni.2006.04.017
3. Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR (2005) Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175:4189–4193. doi:10.4049/jimmunol.175.7.4189
4. Armien AG, Hu S, Little MR, Robinson N, Lokensgard JR, Low WC, Cheeran MC (2009) Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol 20:738–750. doi:10.1111/j.1750-3639.2009.00354.x
5. Atanasiu D, Saw WT, Gallagher JR, Hannah BP, Matsuda Z, Whitbeck JC, Cohen GH, Eisenberg RJ (2013) Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins. J Virol 87:11332–11345. doi:10.1128/JVI. 01700-13
6. Avitabile E, Forghieri C, Campadelli-Fiume G (2009) Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD. J Virol 83:10752–10760. doi:10.1128/JVI.01287-09
7. Awasthi S, Balliet JW, Flynn JA, Lubinski JM, Shaw CE, DiStefano DJ, Cai M, Brown M, Smith JF, Kowalski R, Swoyer R, Galli J, Copeland V, Rios S, Davidson RC, Salnikova M, Kingsley S, Bryan J, Casimiro DR, Friedman HM (2014) Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs. J Virol 88:2000–2010. doi:10.1128/JVI.03163-13
8. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, Ndinya-Achola JO, Jaoko W, Overbaugh J (2007) Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 21:1771–1777. doi:10.1097/QAD.0b013e328270388a
9. Banerjee K, Biswas PS, Rouse BT (2005) Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukoc Biol 77:24–32. doi:10.1189/jlb.0904486
10. Barker KR, Sarafino-Wani R, Khanom A, Griffiths PD, Jacobs MG, Webster DP (2014) Encephalitis in an immunocompetent man. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 59:1–3. doi:10.1016/j.jcv.2013.05.014
11. Barnett EM, Jacobsen G, Evans G, Cassell M, Perlman S (1994) Herpes simplex encephalitis in the temporal cortex and limbic system after trigeminal nerve inoculation. J Infect Dis 169:782–786. doi:10.1093/infdis/169.4.782
12. Barnett EM, Evans GD, Sun N, Perlman S, Cassell MD (1995) Anterograde tracing of trigeminal afferent pathways from the murine tooth pulp to cortex using herpes simplex virus type 1. J Neurosci 15:2972–2984
13. Barr DP, Belz GT, Reading PC, Wojtasiak M, Whitney PG, Heath WR, Carbone FR, Brooks AG (2007) A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur J Immunol 37:1334–1342. doi:10.1002/eji.200636362
14. Bello-Morales R, Fedetz M, Alcina A, Tabarés E, López-Guerrero JA (2005) High susceptibility of a human oligodendroglial cell line to herpes simplex type 1 infection. J Neurovirol 11:190–198. doi:10.1080/13550280590924179
15. Ben-Hur T, Hadar J, Shtram Y, Gilden DH, Becker Y (1983) Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Arch Virol 78:303–308. doi:10.1007/BF01311326
16. Berman EJ, Hill JM (1985) Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest Ophthalmol Vis Sci 26:587–590
17. Bernstein DI, Harrison CJ, Jenski LJ, Myers MG, Stanberry LR (1991) Cell-mediated immunologic responses and recurrent genital herpes in the guinea pig. Effects of glycoprotein immunotherapy. J Immunol 146:3571–3577
18. Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT (2005) Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J Virol 79:10589–10600. doi:10.1128/JVI. 79.16.10589-10600.2005
19. Blackstock R, Murphy JW (2004) Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells. Infect Immun 72:5175–5180. doi:10.1128/IAI. 72.9.5175-5180.2004
20. Boggian I, Buzzacaro E, Calistri A, Calvi P, Cavaggioni A, Mucignat-Caretta C, Palu G (2000) Asymptomatic herpes simplex type 1 virus infection of the mouse brain. J Neurovirol 6:303–313. doi:10.3109/13550280009030756
21. Boivin G, Coulombe Z, Rivest S (2002) Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci 16:29–43. doi:10.1046/j.1460-9568.2002.02057.x
22. Boivin N, Menasria R, Piret J, Boivin G (2012) Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis. Antiviral Res 96:414–421. doi:10.1016/j.antiviral.2012.09.022
23. Bonneau RH, Jennings SR (1989) Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J Virol 63:1480–1484
24. Brown SM, Ritchie DA, Subak-Sharpe JH (1973) Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol 18:329–346. doi:10.1099/0022-1317-18-3-329
25. Bukowski JF, Welsh RM (1986) The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol 136:3481–3485
26. Burl S, Townend J, Njie-Jobe J, Cox M, Adetifa UJ, Touray E, Philbin VJ, Mancuso C, Kampmann B, Whittle H, Jaye A, Flanagan KL, Levy O (2011) Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One 6:e18185. doi:10.1371/journal.pone.0018185
27. Cameron JM, McDougall I, Marsden HS, Preston VG, Ryan DM, Subak-Sharpe JH (1988) Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol 69(Pt 10):2607–2612. doi:10.1099/0022-1317-69-10-2607
28. Campadelli-Fiume G (2007) Menotti L (2007) Entry of alphaherpesviruses into the cell. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, Chapter 7
29. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Héron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova JL (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308–312. doi:10.1126/science.1128346
30. Cassady KA, Gross M, Roizman B (1998) The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J Virol 72:7005–7011
31. Chentoufi AA, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen A, Wu M, Zhu X, Mohebbi A, Buus S, Wechsler SL, Nesburn AB, BenMohamed L (2008) HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol 180:426–437
32. Chentoufi AA, Dasgupta G, Christensen ND, Hu J, Choudhury ZS, Azeem A, Jester JV, Nesburn AB, Wechsler SL, BenMohamed L (2010) A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. J Immunol 184:2561–2571. doi:10.4049/jimmunol.0902322
33. Chung E, Sen J (2012) The ongoing pursuit of a prophylactic HSV vaccine. Rev Med Virol 22:285–300. doi:10.1002/rmv.1709
34. Conrady CD, Zheng M, Fitzgerald KA, Liu C, Carr DJ (2012) Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16. Mucosal Immunol 5:173–183. doi:10.1038/mi.2011.63
35. Conrady CD, Zheng M, van Rooijen N, Drevets DA, Royer D, Alleman A, Carr DJ (2013) Microglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitis. J Immunol 190:2807–2817. doi:10.4049/jimmunol.1203265
36. Daheshia M, Kanangat S, Rouse BT (1998) Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res 67:619–624. doi:10.1006/exer.1998.0565
37. Davey GM, Wojtasiak M, Proietto AI, Carbone FR, Heath WR, Bedoui S (2010) Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J Immunol 184:2243–2246. doi:10.4049/jimmunol.0903013
38. Davison AJ, McGeoch DJ (1986) Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. J Gen Virol 67(Pt 4):597–611
39. Decman V, Freeman ML, Kinchington PR, Hendricks RL (2005) Immune control of HSV-1 latency. Viral Immunol 18:466–473. doi:10.1089/vim.2005.18.466
40. Dennis RF, Siemasko KF, Tang Q, Hendricks RL, Finnegan A (1995) Involvement of LFA-1 and ICAM-1 in the herpetic disease resulting from HSV-1 corneal infection. Curr Eye Res 14:55–62. doi:10.3109/02713689508999914
41. Dervillez X, Qureshi H, Chentoufi AA, Khan AA, Kritzer E, Yu DC, Diaz OR, Gottimukkala C, Kalantari M, Villacres MC, Scarfone VM, McKinney DM, Sidney J, Sette A, Nesburn AB, Wechsler SL, BenMohamed L (2013) Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes. J Immunol 191:5124–5138. doi:10.4049/jimmunol.1301415
42. Dropulic LK, Cohen JI (2012) The challenge of developing a herpes simplex virus 2 vaccine. Expert Rev Vaccines 11:429–1440. doi:10.1586/erv.12.129
43. Duff R, Rapp F (1971) Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol 8:469–477
44. Ecob-Johnston MS, Whetsell WO Jr (1979) Host-cell response to herpes virus infection in central and peripheral nervous tissue in vitro. J Gen Virol 44:747–757. doi:10.1099/0022-1317-44-3-747
45. Ejercito PM, Kieff ED, Roizman B (1968) Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2:357–364. doi:10.1099/0022-1317-2-3-357
46. Eloranta ML, Sandberg K, Alm GV (1996) The interferon-alpha/beta responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo. Scand J Immunol 43:356–360
47. Engler H, Zawatzky R, Goldbach A, Schroder CH, Weyand C, Hammerling GJ, Kirchner H (1981) Experimental infection of inbred mice with herpes simplex virus II. Interferon production and activation of natural killer cells in the peritoneal exudate. J Gen Virol 55:25–30. doi:10.1099/0022-1317-55-1-25
48. Engler H, Zawatzky R, Kirchner H, Armerding D, Engler H, Zawatzky R, Kirchner H, Armerding D (1982) Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice. Arch Virol 74(74):239–247. doi:10.1007/BF01314157
49. Esaki S, Goshima F, Katsumi S, Watanabe D, Ozaki N, Murakami S, Nishiyama Y (2010) Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo. Arch Virol 155:1235–1245. doi:10.1007/s00705-010-0712-2
50. Field HJ, Wildy P (1978) The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J Hyg (Lond) 81:267–277
51. Forrester JV, Xu H, Kuffova L, Dick AD, McMenamin PG (2010) Dendritic cell physiology and function in the eye. Immunol Rev 234:282–304. doi:10.1111/j.0105-2896.2009.00873.x
52. Greco A, Arata L, Soler E, Gaume X, Couté Y, Hacot S, Callé A, Monier K, Epstein AL, Sanchez JC, Bouvet P, Diaz JJ (2012) Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking. J Virol 86:1449–1457. doi:10.1128/JVI. 06194-11
53. Gudnadottir M, Helgadottir H, Bjarnason O, Jonsdottir K (1964) Virus isolated from the brain of a patient with multiple sclerosis. Exp Neurol 9:85–95. doi:10.1016/0014-4886(64)90008-1
54. Guo YJ, Zhao L, Li XF, Mei YW, Zhang SL, Tao JY, Zhou Y, Dong JH (2010) Effect of Corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias. Eur J Pharmacol 635:79–86. doi:10.1016/j.ejphar.2010.02.049
55. Hankenson FC, Ruskoski N, van Saun M, Ying GS, Oh J, Fraser NW (2013) Weight loss and reduced body temperature determine humane endpoints in a mouse model of ocular herpesvirus infection. J Am Assoc Lab Anim Sci 52:277–285
56. Hawkins P, Morton DB, Burman O, Dennison N, Honess P, Jennings M, Lane S, Middleton V, Roughan JV, Wells S, Westwood K, UK Joint Working Group on Refinement BVAAWF/FRAME/RSPCA/UFAW (2011) A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Lab Anim 45:1–13. doi:10.1258/la.2010.010031
57. Hendricks RL, Tumpey TM, Finnegan A (1992) IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol 149:3023–3028
58. Herman M, Ciancanelli M, Ou YH, Lorenzo L, Klaudel-Dreszler M, Pauwels E, Sancho-Shimizu V, Perez de Diego R, Abhyankar A, Israelsson E, Guo Y, Cardon A, Rozenberg F, Lebon P, Tardieu M, Heropolitanska-Pliszka E, Chaussabel D, White MA, Abel L, Zhang SY, Casanova JL (2012) Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med 209:1567–1582. doi:10.1084/jem.20111316
59. Hoffmann F, Albert MH, Arenz S, Bidlingmaier C, Berkowicz N, Sedlaczek S, Till H, Pawlita I, Renner ED, Weiss M, Belohradsky BH (2005) Intracellular T-cell cytokine levels are age-dependent in healthy children and adults. Eur Cytokine Netw 16:283–288
60. Hsiung GD, Mayo DR, Lucia HL, Landry ML (1984) Genital herpes: pathogenesis and chemotherapy in the guinea pig model. Rev Infect Dis 6:33–50, http://www.jstor.org/stable/4453263
61. Hu J, Peng X, Schell TD, Budgeon LR, Cladel NM, Christensen ND (2006) An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection. J Immunol 177:8037–8045. doi:10.4049/jimmunol.177.11.8037
62. Irvine AR, Kimura SJ (1967) Experimental stromal herpes simplex keratitis in rabbits. Arch Ophthalmol 78:654–663. doi:10.1001/archopht.1967.00980030656018
63. Ishikawa H, Ma Z, Barber GN (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788–792. doi:10.1038/nature08476
64. Iyer AV, Pahar B, Chouljenko VN, Walker JD, Stanfield B, Kousoulas KG (2013) Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses. Virol J 10:317. doi:10.1186/1743-422X-10-317
65. Johnson RT (1964) The pathogenesis of herpes virus encephalitis. II. A cellular basis for the development of resistance with age. J Exp Med 120:359–374. doi:10.1084/jem.120.3.359
66. Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT (1996) Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 156:1110–1116
67. Kastrukoff LF, Kim SU (2002) Oligodendrocytes from human donors differ in resistance to herpes simplex virus 1 (HSV-1). Glia 38:87–92. doi:10.1002/glia.10043
68. Kastrukoff L, Long C, Doherty PC, Wroblewska Z, Koprowski H (1981) Isolation of virus from brain after immunosuppression of mice with latent herpes simplex. Nature 291:432–433. doi:10.1038/291432a0
69. Kastrukoff L, Hamada T, Schumacher U, Long C, Doherty PC, Koprowski H (1982) Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1. J Neuroimmunol 2:295–305. doi:10.1016/0165-5728(82)90062-5
70. Kastrukoff LF, Lau AS, Puterman ML (1986) Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice. J Gen Virol 67(Pt 4):613–621. doi:10.1099/0022-1317-67-4-613
71. Kastrukoff LF, Lau AS, Kim SU (1987) Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1. Ann Neurol 22:52–59. doi:10.1002/ana.410220113
72. Kastrukoff LF, Lau AS, Leung GY, Walker DG, Thomas EE (1992) Herpes simplex virus type I (HSV I)-induced multifocal central nervous system (CNS) demyelination in mice. J Neuropathol Exp Neurol 51:432–439
73. Kastrukoff LF, Lau AS, Takei F, Smyth MJ, Jones CM, Clarke SR, Carbone FR (2010) Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice. Virology 400:248–258. doi:10.1016/j.virol.2010.02.013
74. Kastrukoff LF, Lau AS, Thomas EE (2012) The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS). Herpesviridae 3:4. doi:10.1186/2042-4280-3-4
75. Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL (2003) Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18:593–603. doi:10.1016/S1074-7613(03)00112-2
76. Kintner RL, Brandt CR (1995) The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Curr Eye Res 14:145–152. doi:10.3109/02713689508999926
77. Kirchner H, Engler H, Schroder CH, Zawatzky R, Storch E (1983) Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice. J Gen Virol 64(Pt 2):437–441. doi:10.1099/0022-1317-64-2-437
78. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL (2008) Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268–271. doi:10.1126/science.1164164
79. Kopp SJ, Banisadr G, Glajch K, Maurer UE, Grunewald K, Miller RJ, Osten P, Spear PG (2009) Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc Natl Acad Sci U S A 106:17916–17920. doi:10.1073/pnas.0908892106
80. Kopp SJ, Karaba AH, Cohen LK, Banisadr G, Miller RJ, Muller WJ (2013) Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation. J Virol 87:474–481. doi:10.1128/JVI. 01849-12
81. Ksander BR, Hendricks RL (1987) Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest Ophthalmol Vis Sci 28:1986–1993
82. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 101:1315–1320. doi:10.1073/pnas.0308057100
83. Labetoulle M, Kucera P, Ugolini G, Lafay F, Frau E, Offret H, Flamand A (2000) Neuronal propagation of HSV1 from the oral mucosa to the eye. Invest Ophthalmol Vis Sci 41:2600–2606
84. Laing KJ, Magaret AS, Mueller DE, Zhao L, Johnston C, De Rosa SC, Koelle DM, Wald A, Corey, L (2010) Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes. J Clin Immunol 30:703–722. doi:10.1007/s10875-010-9441-2
85. Laquerre S, Argnani R, Anderson DB, Zucchini S, Manservigi R, Glorioso JC (1998) Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 72:6119–6130
86. Lee AJ, Ashkar AA (2012) Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development. Curr Opin Infect Dis 25:92–99. doi:10.1097/QCO.0b013e32834e9a56
87. Leib DA, Alexander DE, Cox D, Yin J, Ferguson TA (2009) Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control of CD4+ T-cell responses. J Virol 83:12164–12171. doi:10.1128/JVI. 01676-09
88. Liu F (2007) Hong Zhou Z (2007) Comparative virion structures of human herpesviruses. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, Chapter 3
89. Liu T, Tang Q, Hendricks, RL (1996) Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 70:264–271
90. Liu T, Khanna KM, Chen X, Fink DJ, Hendricks, RL (2000) CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191:1459–1466. doi:10.1084/jem.191.9.1459
91. Liu T, Khanna KM, Carriere BN, Hendricks, RL (2001) Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 75:11178–11184. doi:10.1128/JVI.75.22.11178-11184
92. Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK (2001) Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol 7:208–219
93. Lopez C (1975) Genetics of natural resistance to herpesvirus infections in mice. Nature 258:152–153. doi:10.1038/258152a0
94. Lund JM, Linehan MM, Iijima N, Iwasaki A (2006) Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 177:7510–7514. doi:10.4049/jimmunol.177.11.7510
95. Margolis TP, Imai Y, Yang L, Vallas V, Krause PR (2007) Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J Virol 81:1872–1878. doi:10.1128/JVI. 02110-06
96. Marodi L (2006) Neonatal innate immunity to infectious agents. Infect Immun 74:1999–2006. doi:10.1128/IAI. 74.4.1999-2006.2006
97. Marques CP, Cheeran MC, Palmquist JM, Hu S, Urban SL, Lokensgard JR (2008) Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol 181:6417–6426. doi:10.4049/jimmunol.181.9.6417
98. Martin R, Nauta AJ, Ben Amor K, Knippels LM, Knol J, Garssen J (2011) Early life: gut microbiota and immune development in infancy. Benef Microbes 1:367–382. doi:10.3920/BM2010.0027
99. McKendall RR (1980) Comparative neurovirulence and latency of HSV1 and HSV2 following footpad inoculation in mice. J Med Virol 5:25–32. doi:10.1002/jmv.1890050104
100. McNally JM, Dempsey D, Wolcott RM, Chervenak R, Jennings SR (1999) Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection. J Immunol 163:675–681
101. Meyding-Lamadé UK, Oberlinner C, Rau PR, Seyfer S, Heiland S, Sellner J, Wildemann BT, Lamadé WR (2003) Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 9:118–125. doi:10.1080/713831335
102. Mou F, Forest T, Baines JD (2007) US3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J Virol 81:6459–6470. doi:10.1128/JVI. 00380-07
103. Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, Zhang W, Burns D, Leib DA, Levine B (2007) HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1:23–35. doi:10.1016/j.chom.2006.12.001
104. Pan M, Wang X, Liao J, Yin D, Li S, Pan Y, Wang Y, Xie G, Zhang S, Li Y (2012) Prediction and identification of potential immunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2. Clin Dev Immunol 2012:205313. doi:10.1155/2012/205313
105. Parr MB, Parr EL (2003) Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J Neurovirol 9:594–602. doi:10.1080/714044481
106. Peng T, Zhu J, Phasouk K, Koelle DM, Wald A, Corey, L (2012) An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection. J Virol 86:10587–10596. doi:10.1128/JVI.01237-12
107. Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, Vallabhapurapu S, Bravo J, Warnatz K, Chaix Y, Cascarrigny F, Lebon P, Rozenberg F, Karin M, Tardieu M, Al-Muhsen S, Jouanguy E, Zhang SY, Abel L, Casanova JL (2010) Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:400–411. doi:10.1016/j.immuni.2010.08.014
108. Piret J, Boivin G (2010) Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55:459–472. doi:10.1128/AAC. 00615-10
109. Rawls WE, Laurel D, Melnick JL, Glicksman JM, Kaufman RH (1968) A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol 87:647–655
110. Rhee SJ, Walker WA, Cherayil BJ (2005) Developmentally regulated intestinal expression of IFN-gamma and its target genes and the age-specific response to enteric Salmonella infection. J Immunol 175:1127–1136. doi:10.4049/jimmunol.175.2.1127
111. Roberts CM, Pfister JR, Spear SJ (2003) Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 30:797–800. doi:10.1097/01.OLQ.0000092387.58746.C7
112. Roizman B (1996) The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci U S A 93:11307–11312. doi:10.1073/pnas.93.21.11307
113. Rollenhagen C, Lathrop MJ, Macura SL, Doncel GF, Asin SN (2014) Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides. Mucosal Immunol. doi:10.1038/mi.2014.3
114. Roth K, Ferreira VH, Kaushic C (2013) HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection. Microb Pathog 58:45–54. doi:10.1016/j.micpath.2012.11.001
115. Russell RG, Nasisse MP, Larsen HS, Rouse BT (1984) Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 25:938–944
116. Sancho-Shimizu V, Perez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, Fabrega S, Cardon A, Maluenda J, Tatematsu M, Mahvelati F, Herman M, Ciancanelli M, Guo Y, AlSum Z, Alkhamis N, Al-Makadma AS, Ghadiri A, Boucherit S, Plancoulaine S, Picard C, Rozenberg F, Tardieu M, Lebon P, Jouanguy E, Rezaei N, Seya T, Matsumoto M, Chaussabel D, Puel A, Zhang SY, Abel L, Al-Muhsen S, Casanova JL (2011) Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 121:4889–4902. doi:10.1172/JCI59259
117. Sarangi PP, Sehrawat S, Suvas S, Rouse BT (2008) IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J Immunol 180:6297–6306. doi:10.4049/jimmunol.180.9.6297
118. Schachtele SJ, Hu S, Little MR, Lokensgard JR (2010) Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation 7:35. doi:10.1186/1742-2094-7-35
119. Schachtele SJ, Hu S, Lokensgard JR (2012) Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment. PLoS One 7:e36216. doi:10.1371/journal.pone.0036216
120. Sehrawat S, Suvas S, Sarangi PP, Suryawanshi A, Rouse BT (2008) In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J Virol 82:6838–6851. doi:10.1128/JVI.00697-08
121. Shimeld C, Dyson H, Lewkowicz-Moss S, Hill TJ, Blyth WA, Easty DL (1987) Spread of HSV-1 to the mouse eye after inoculation in the skin of the snout requires an intact nerve supply to the inoculation site. Curr Eye Res 6:9–12. doi:10.3109/02713688709020061
122. Shimomura Y, Dudley JB, Gangarosa LP Sr, Hill JM (1985) HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation. Invest Ophthalmol Vis Sci 26:121–125
123. Shin H, Iwasaki A (2013) Generating protective immunity against genital herpes. Trends Immunol 34:487–494. doi:10.1016/j.it.2013.08.001
124. Simmons A (2002) Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis 186(Suppl 1):S71–S77. doi:10.1086/342967
125. Simmons A, Nash AA (1984) Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol 52:816–821
126. Simmons A, Nash AA (1985) Role of antibody in primary and recurrent herpes simplex virus infection. J Virol 53:944–948
127. Simmons A, Nash AA (1987) Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis 155:649–654. doi:10.1093/infdis/155.4.649
128. Simmons A, Slobedman B, Speck P, Arthur J, Efstathiou S (1992) Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice. J Gen Virol 73(Pt 5):1287–1291. doi:10.1099/0022-1317-73-5-1287
129. Skoberne M, Cardin R, Lee A, Kazimirova A, Zielinski V, Garvie D, Lundberg A, Larson S, Bravo FJ, Bernstein DI, Flechtner JB, Long D (2013) An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs. J Virol 87:3930–3942. doi:10.1128/JVI. 02745-12
130. Smith G (2012) Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol 66:153–176. doi:10.1146/annurev-micro-092611-150051
131. Sprecher E, Becker Y (1987) Herpes simplex virus type 1 pathogenicity in footpad and ear skin of mice depends on Langerhans cell density, mouse genetics, and virus strain. J Virol 61:2515–2522
132. Steiner CM, Rozhon EJ, Lipton HL (1984) Relationship between host age and persistence of Theiler's virus in the central nervous system of mice. Infect Immun 43:432–434
133. Steiner I, Spivack JG, Deshmane SL, Ace CI, Preston CM, Fraser NW (1990) A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J Virol 64:1630–1638
134. Stumpf TH, Case R, Shimeld C, Easty DL, Hill TJ (2002) Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J Gen Virol 83:1579–1590
135. Svensson A, Bellner L, Magnusson M, Eriksson K (2007) Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection. J Reprod Immunol 74:114–123. doi:10.1016/j.jri.2006.09.002
136. Teague O, Goodpasture EW (1923) Experimental herpes zoster. JAMA 81:377. doi:10.1001/jama.1923.02650050031010
137. Theil D, Derfuss T, Paripovic I, Herberger S, Meinl E, Schueler O, Strupp M, Arbusow V, Brandt T (2003) Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 163:2179–2184. doi:10.1016/S0002-9440(10)63575-4
138. Thomas EE, Lau AS, Kim SU, Osborne D, Kastrukoff LF (1991) Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice. J Gen Virol 72(Pt 9):2051–2057. doi:10.1099/0022-1317-72-9-2051
139. Tigges MA, Koelle D, Hartog K, Sekulovich RE, Corey L, Burke, RL (1992) Human CD8+ herpes simplex virus-specific cytotoxic Tlymphocyte clones recognize diverse virion protein antigens. J Virol 66:1622–1634
140. Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempe P, Fruh K, Johnson DC (1998) Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 72:2560–2563
141. Toth LA (2000) Defining the moribund condition as an experimental endpoint for animal research. ILAR J 41:72–79. doi:10.1093/ilar.41.2.72
142. Ushijima Y, Luo C, Goshima F, Yamauchi Y, Kimura H, Nishiyama Y (2007) Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus. Microbes Infect 9:142–149. doi:10.1016/j.micinf.2006.10.019
143. Valencia F, Veselenak RL, Bourne N (2013) In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models. Methods Mole Biol 1030:315–326. doi:10.1007/978-1-62703-484-5_24
144. Verjans GM, Feron EJ, Dings ME, Cornelissen JG, Van der Lelij A, Baarsma GS, Osterhaus, AD (1998) T cells specific for the triggering virus infiltrate the eye in patients with herpes simplex virus-mediated acute retinal necrosis. J Infect Dis 178:27–34. doi:10.1086/515586
145. Verjans GM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR, Osterhaus, AD (2007) Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A 104:3496–3501. doi:10.1073/pnas.0610847104
146. Vilela MC, Campos RD, Mansur DS, Rodrigues DH, Lacerda-Queiroz N, Lima GK, Rachid MA, Kroon EG, Campos MA, Teixeira AL (2011) Role of IL-4 in an experimental model of encephalitis induced by intracranial inoculation of herpes simplex virus-1 (HSV-1). Arq Neuropsiquiatr 69:237–241. doi:10.1590/S0004-282X2011000200019
147. Villalba M, Hott M, Martin C, Aguila B, Valdivia S, Quezada C, Zambrano A, Concha MI, Otth C (2012) Herpes simplex virus type 1 induces simultaneous activation of Toll-like receptors 2 and 4 and expression of the endogenous ligand serum amyloid A in astrocytes. Med Microbiol Immunol 201:371–379. doi:10.1007/s00430-012-0247-0
148. Wagner EK, Bloom DC (1997) Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev 10:419–443
149. Wander AH, Centifanto YM, Kaufman HE (1980) Strain specificity of clinical isolates of herpes simplex virus. Arch Ophthalmol 98:1458–1461. doi:10.1001/archopht.1980.01020040310020
150. Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA (2011) Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 86:2273–2281. doi:10.1128/JVI. 06010-11
151. Ward PL, Roizman B (1994) Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet 10:267–274. doi:10.1016/0168-9525(90)90009-U
152. Whitley RJ (2006) Herpes simplex encephalitis: adolescents and adults. Antiviral Res 71:141–148. doi:10.1016/j.antiviral.2006.04.002
153. Whitley RJ, Roizman B (2001) Herpes simplex virus infections. Lancet 357:1513–1518. doi:10.1016/S0140-6736(00)04638-9
154. Zawatzky R, Engler H, Kirchner H (1982a) Experimental infection of inbred mice with herpes simplex virus. III. Comparison between newborn and adult C57BL/6 mice. J Gen Virol 60:25–29. doi:10.1099/0022-1317-60-1-25
155. Zawatzky R, Kirchner H, DeMaeyer-Guignard J, DeMaeyer E (1982b) An X-linked locus influences the amount of circulating interferon induced in the mouse by herpes simplex virus type 1. J Gen Virol 63:325–332. doi:10.1099/0022-1317-63-2-325
156. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527
157. Zhang X, Castelli FA, Zhu X, Wu M, Maillere B, BenMohamed L (2008) Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. Clin Vaccine Immunol 15:1436–1449. doi:10.1128/CVI. 00123-08